Naoki Okamoto, Kenta Yagi, Sayaka Imawaka, Mayu Takaoka, Fuka Aizawa, Takahiro Niimura, . . . Keisuke Ishizawa. (2024). Asciminib, a novel allosteric inhibitor of BCR‐ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance. Wiley.
Chicago Style (17th ed.) CitationNaoki Okamoto, et al. Asciminib, a Novel Allosteric Inhibitor of BCR‐ABL1, Shows Synergistic Effects When Used in Combination with Imatinib with or Without Drug Resistance. Wiley, 2024.
MLA (9th ed.) CitationNaoki Okamoto, et al. Asciminib, a Novel Allosteric Inhibitor of BCR‐ABL1, Shows Synergistic Effects When Used in Combination with Imatinib with or Without Drug Resistance. Wiley, 2024.
Warning: These citations may not always be 100% accurate.